Articles about Zydus Cadila

Zydus Cadila is a multinational pharmaceutical company based in Ahmedabad, Gujarat. The company is also known as Cadila Healthcare Limited and is primarily engaged in the manufacturing of generic drugs. In 2020, it ranked 100 on the Fortune India 500 list. Cadila was founded in 1952 by Ramanbhai B. Patel (late) and his business partner Indravadan Modi. In 1995, the Patel and Mody families split and the latter's share was moved into a new company called Cadila Pharmaceuticals Limited. Cadila Healthcare remained the Patel family’s holding. It made its initial public offering on the Bombay Stock Exchange in 2000. In the fiscal year 2021, Cadila healthcare generated total revenue of ₹15,139 crores, of which the company's net income was ₹2,133 crores. As of 2021, Zydus Cadila employs 25,000 people. This is a stellar growth for Zydus Cadila that had a turnover of ₹250 crores in 1995 when the families split.

Zydus Cadila's vaccine rollout likely in two weeks: Report

04 Oct 2021

Zydus Cadila's vaccine rollout likely in two weeks: Report

The indigenous COVID-19 vaccine developed by Zydus Cadila, called ZyCoV-D, is likely to be rolled out in the next two weeks.

Here are some key drugs being tested for COVID-19 treatment

02 Oct 2021

Here are some key drugs being tested for COVID-19 treatment

Several antiviral drugs are being developed and tested for COVID-19 treatment as scientists around the world race to find new methods to fight the pandemic and ease the burden on hospitals.

NTAGI to devise roadmap to introduce ZyCoV-D into inoculation drive

25 Aug 2021

NTAGI to devise roadmap to introduce ZyCoV-D into inoculation drive

The National Technical Advisory Group on Immunization (NTAGI) will soon hold a meeting to devise a roadmap for introducing Zydus Cadila's COVID-19 vaccine in the inoculation drive and prioritizing beneficiaries focusing on those aged 12-18 years with comorbidities.

COVID-19 vaccine trials for ages 3-12 soon: Zydus Cadila MD

22 Aug 2021

COVID-19 vaccine trials for ages 3-12 soon: Zydus Cadila MD

After receiving emergency use approval for its COVID-19 vaccine, Zydus Cadila will now submit an application to start vaccine trials for children aged 3-12 years, Managing Director Dr. Sharvil Patel said Saturday.

Zydus Cadila's COVID-19 vaccine approved. What you need to know

21 Aug 2021

Zydus Cadila's COVID-19 vaccine approved. What you need to know

Zydus Cadila's three-dose coronavirus vaccine has received the emergency use authorization from India's top drug regulator, becoming the sixth jab to get the nod in the country.

Expert panel recommends emergency use authorization for Zydus's three-dose vaccine

20 Aug 2021

Expert panel recommends emergency use authorization for Zydus's three-dose vaccine

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting an emergency use authorization (EUA) to ZyCoV-D, the three-dose COVID-19 vaccine developed by Zydus Cadila, on Friday.

COVID-19 vaccine for children likely by September, says ICMR-NIV chief

18 Aug 2021

COVID-19 vaccine for children likely by September, says ICMR-NIV chief

India will likely have a COVID-19 vaccine for children by next month, Dr. Priya Abraham said in an interview.

Zydus Cadila COVID-19 vaccine may get emergency nod this week

10 Aug 2021

Zydus Cadila COVID-19 vaccine may get emergency nod this week

India's second indigenous COVID-19 vaccine, developed by Zydus Cadila, is reportedly likely to get emergency use approval (EUA) this week.

COVID-19 vaccines for children likely by September, says AIIMS chief

24 Jul 2021

COVID-19 vaccines for children likely by September, says AIIMS chief

India will likely have its first coronavirus vaccine for children by September, said Dr. Randeep Guleria, the chief of Delhi's All India Institute of Medical Sciences (AIIMS).

Zydus vaccine for 12-18-year-olds from September, says expert panel chief

09 Jul 2021

Zydus vaccine for 12-18-year-olds from September, says expert panel chief

Coronavirus vaccination for children with the Zydus Cadila vaccine will start by September, said Dr. NK Arora, the chief of National Expert Group on Vaccine Administration.

Zydus applies for approval of its 3-dose, needle-free COVID-19 vaccine

01 Jul 2021

Zydus applies for approval of its 3-dose, needle-free COVID-19 vaccine

Zydus Cadila, the Gujarat-based drug firm, has applied for the Emergency Use Authorization (EUA) of its COVID-19 vaccine to the Drugs Controller General of India (DCGI), the company said today.

Zydus to seek approval for its COVID-19 vaccine next week

19 Jun 2021

Zydus to seek approval for its COVID-19 vaccine next week

Zydus Cadila, the Gujarat-based drug firm, will next week apply for the emergency use authorization (EUA) of its COVID-19 vaccine in India, company sources told the media, adding it has apprised the government of its intention.

Zydus seeks human trial approval for its COVID-19 antibody cocktail

27 May 2021

Zydus seeks human trial approval for its COVID-19 antibody cocktail

Indian pharmaceutical firm Zydus Cadila has sought permission from the Drugs Controller General of India (DCGI) to conduct human clinical trials of its antibody cocktail meant to treat mild COVID-19 patients.

Zydus Cadila's antiviral drug approved for treating moderate COVID-19 cases

23 Apr 2021

Zydus Cadila's antiviral drug approved for treating moderate COVID-19 cases

The Drugs Controller General of India (DCGI) on Friday gave approval for the emergency use of Zydus Cadila's Hepatitis C drug "Virafin" for the treatment of moderate coronavirus infection in adults.

India's neighbors train experts for clinical trials of COVID-19 vaccine

17 Dec 2020

India's neighbors train experts for clinical trials of COVID-19 vaccine

India's friendly neighboring nations trained over 100 experts to strengthen capacities in their countries for facilitating phase-3 clinical trials of the Indian COVID-19 vaccine, a senior official of the Department of Biotechnology said.

Modi to chair all-party meet to review COVID-19 situation Friday

30 Nov 2020

Modi to chair all-party meet to review COVID-19 situation Friday

Prime Minister Narendra Modi is set to chair an all-party meeting this Friday to review the COVID-19 situation in India, according to reports.

Applying for Covishield's emergency approval in 2 weeks: SII

28 Nov 2020

Applying for Covishield's emergency approval in 2 weeks: SII

The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.

Modi embarks on 3-city tour to view COVID-19 vaccine development

28 Nov 2020

Modi embarks on 3-city tour to view COVID-19 vaccine development

Prime Minister Narendra Modi on Saturday embarked on a three-city tour to review the development of COVID-19 vaccines.

PM to visit three cities to review coronavirus vaccine development

28 Nov 2020

PM to visit three cities to review coronavirus vaccine development

Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.

Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

08 Nov 2020

Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

Vaccine tracker: Covishield expected by December; Moderna readies for launch

01 Nov 2020

Vaccine tracker: Covishield expected by December; Moderna readies for launch

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.

COVAXIN to Oxford: Coronavirus vaccine updates for India

12 Oct 2020

COVAXIN to Oxford: Coronavirus vaccine updates for India

Although the coronavirus outbreak in India has started to slow down, the country remains the second worst-hit in the world.

Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government

04 Oct 2020

Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government

The Indian government is planning to provide vaccines to roughly 25 crore people by July 2021, Union Health Minister Dr. Harsh Vardhan said on Sunday.

Vaccine expected by early 2021; nationwide immunization a challenge: Scientist

22 Sep 2020

Vaccine expected by early 2021; nationwide immunization a challenge: Scientist

A vaccine for COVID-19 is likely to be ready by early 2021, a leading vaccine scientist has said. However, the real challenge for India would be conducting a vaccination drive for its population of 1.3 billion.

#VaccineTracker: Early COVID-19 vaccine results expected by September 15

04 Sep 2020

#VaccineTracker: Early COVID-19 vaccine results expected by September 15

As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.

Indian government starts talks to procure COVID-19 vaccine: Details here

18 Aug 2020

Indian government starts talks to procure COVID-19 vaccine: Details here

Amid surging COVID-19 cases and questions over the peak for India, the government has started working towards procuring a vaccine.

Three indigenous coronavirus vaccines in trials, distribution plan ready: PM

15 Aug 2020

Three indigenous coronavirus vaccines in trials, distribution plan ready: PM

With the world counting on a coronavirus vaccine to save it from the disease that has taken 763,572 lives so far, Prime Minister Narendra Modi on Saturday said India is ready to mass-produce the vaccine once it's developed.

Coronavirus: Zydus Cadila launches cheapest version of Remdesivir in India

13 Aug 2020

Coronavirus: Zydus Cadila launches cheapest version of Remdesivir in India

In a major development, Zydus Cadila has launched the cheapest generic version of Remdesivir, the antiviral drug being used to treat COVID-19, in India.

Israel claims to have 'excellent' COVID-19 vaccine in hand

07 Aug 2020

Israel claims to have 'excellent' COVID-19 vaccine in hand

Israel says it has an 'excellent' vaccine in hand to prevent COVID-19, the novel coronavirus disease.

NewsBytes Briefing: Facebook, Twitter remove Trump's misleading post, and more

06 Aug 2020

NewsBytes Briefing: Facebook, Twitter remove Trump's misleading post, and more

In the updates since last night, both Facebook and Twitter launched a crackdown on a misleading post from US President Donald Trump.

Zydus Cadila's COVID-19 vaccine found safe, going into Phase-2 trial

05 Aug 2020

Zydus Cadila's COVID-19 vaccine found safe, going into Phase-2 trial

Indian drug company Zydus Cadila has completed early-stage human trials with its indigenously developed COVID-19 vaccine.

NewsBytes Briefing: Apple refreshes iMac, ex-Google exec gets prison term

05 Aug 2020

NewsBytes Briefing: Apple refreshes iMac, ex-Google exec gets prison term

In the updates since last night, Apple unveiled a refreshed 27-inch iMac.

As coronavirus cases surge, PM to meet CMs next week

25 Jul 2020

As coronavirus cases surge, PM to meet CMs next week

Prime Minister Narendra Modi is likely to convene a virtual meeting with Chief Ministers of all states on July 27, Monday, to discuss the coronavirus situation in their respective regions and the steps taken to mitigate the effect of the biggest health crisis in a century.

India's COVID-19 vaccines: What are the latest updates?

17 Jul 2020

India's COVID-19 vaccines: What are the latest updates?

In the race to develop a vaccine for the novel coronavirus disease (COVID-19), two pharma companies are leading the way from India - Bharat Biotech and Zydus Cadila.

All you need to know about India's COVID-19 vaccines

09 Jul 2020

All you need to know about India's COVID-19 vaccines

As the coronavirus outbreak continues to surge worldwide, efforts to develop a vaccine have been expedited.

COVID-19 vaccine: What are the latest updates?

05 Jul 2020

COVID-19 vaccine: What are the latest updates?

With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.

India's second COVID-19 vaccine cleared for human trials: Details here

03 Jul 2020

India's second COVID-19 vaccine cleared for human trials: Details here

India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.

These drugs are in use for COVID-19 treatment in India

24 Jun 2020

These drugs are in use for COVID-19 treatment in India

India has opened up, but the pandemic is not slowing down.

COVID KAVACH ELISA: First Indian antibody detection kit for coronavirus

11 May 2020

COVID KAVACH ELISA: First Indian antibody detection kit for coronavirus

In a major step forward, the Indian Council of Medical Research and National Institute of Virology have jointly announced the development of COVID KAVACH ELISA, the first indigenous antibody detection kit for COVID-19.

GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance

26 Sep 2019

GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance

Amid an ongoing probe into Ranitidine's reported cancer-causing impurities, GlaxoSmithKline Pharmaceuticals Limited (GSK) has recalled Ranitidine-based antacid Zinetac (150mg and 300mg) in India and other markets.